Aytu BiopharmaAYTU
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 38 institutions reported holding Aytu Biopharma Inc. (AYTU) in their 13F filings, up 1 from Q1 2026. 3 opened new positions and 2 sold out. The largest holders were Nantahala Capital Management, LLC ($2.3M), Stonepine Capital Management, LLC ($2.0M) and AWM Investment Company, Inc. ($1.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aytu Biopharma Inc.
- CUSIP
- 054754858
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $121 |
| Exits | 2 | $10K |
All 13F filers, Q1 2026 → Q2 2026: 212,613 shares bought and 279,854 shares sold, net −67,241 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Nantahala Capital Management, LLC | 0.14% | No change | 1,086,812 | $2.3M |
| Stonepine Capital Management, LLC | 1.49% | Add +15.2% | 912,921 | $2.0M |
| AWM Investment Company, Inc. | 0.12% | No change | 619,574 | $1.3M |
| Vanguard Capital Management LLC | 0.00% | No change | 261,146 | $561K |
| Crown Advisors Management, Inc. | 0.24% | Add +37.9% | 200,000 | $430K |
| Diadema Partners LP | 0.12% | Reduce -57.9% | 148,546 | $319K |
| Two Sigma Investments, LP | 0.00% | Reduce -13.7% | 105,326 | $226K |
| Renaissance Technologies | 0.00% | Add +11.8% | 104,823 | $225K |
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 93,647 | $201K |
| Citadel Advisors | 0.00% | Add +34.1% | 49,414 | $106K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 47,048 | $101K |
| Dimensional Fund Advisors LP | 0.00% | Add +4.0% | 45,326 | $97K |
| Persistent Asset Partners Ltd | 0.03% | Reduce -59.1% | 37,984 | $82K |
| Northern Trust Corp. | 0.00% | Add +45.7% | 27,925 | $60K |
| Bellevue Asset Management, LLC | 0.02% | No change | 25,013 | $54K |
| BlackRock, Inc. | 0.00% | No change | 22,793 | $49K |
| XTX Topco Ltd | 0.00% | Reduce -0.8% | 21,416 | $46K |
| Daytona Street Capital LLC | 0.02% | No change | 10,000 | $22K |
| Acadian Asset Management LLC | 0.00% | No change | 10,237 | $22K |
| UBS Group AG | 0.00% | Add +42.9% | 2,377 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +42.7% | 2,232 | $5K |
| Royal Bank of Canada | 0.00% | Add +950.0% | 378 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 462 | $991 |
| JPMorgan Chase & Co. | 0.00% | No change | 154 | $337 |
| Wells Fargo & Company | 0.00% | No change | 127 | $273 |
| Morgan Stanley | 0.00% | No change | 125 | $269 |
| Barclays PLC | 0.00% | New | 50 | $108 |
| Group One Trading LLC | 0.00% | No change | 37 | $80 |
| BNP Paribas Financial Markets | 0.00% | No change | 23 | $49 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 10 | $22 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -9.1% | 10 | $22 |
| Farther Finance Advisors, LLC | 0.00% | New | 4 | $9 |
| Vision Financial Markets LLC | 0.00% | No change | 2 | $5 |
| Arax Advisory Partners | 0.00% | New | 2 | $4 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 2 | $4 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $2 |
| FNY Investment Advisers, LLC | 0.00% | Add +22.2% | 110 | $0 |
| Tsfg, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is AYTU's weight in each manager's 13F, not the share of Aytu Biopharma Inc. the manager owns.